R R - American Society of Gene & Cell Therapy
R R - American Society of Gene & Cell Therapy
R R - American Society of Gene & Cell Therapy
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
The <strong>American</strong> <strong>Society</strong> <strong>of</strong> <strong>Gene</strong> <strong>Therapy</strong>’s<br />
2004<br />
7th Annual Meeting<br />
final program<br />
Saturday, June 5<br />
OA415 – <strong>Gene</strong> Transfer into Hematopoietic Stem/<br />
Progenitor <strong>Cell</strong>s<br />
Room: 102 A-C<br />
Moderators<br />
C. Anthony Blau, MD<br />
Jan Nolta, PhD<br />
(Abstracts #701 - #708)<br />
OA416 – <strong>Gene</strong> Regulation: <strong>Gene</strong> Modification and<br />
New Methods<br />
Room: 211 A-D<br />
Moderators<br />
Brian Johnstone, PhD<br />
Matthew H. Porteus, MD, PhD<br />
(Abstracts #709 - #716)<br />
Meet-the-Investigator Sessions<br />
12:15 pm – 1:15 pm<br />
The Meet-the-Investigator sessions are designed to<br />
provide an opportunity for participants to interact<br />
with investigators and discuss topics related to their<br />
research. A lunch will be served during the program,<br />
which will begin at 12:15 pm and last for<br />
approximately one hour.<br />
The Meet-the-Investigator sessions require tickets for<br />
admission. Tickets for these sessions are not included<br />
in the regular registration fees to attend the meeting.<br />
Ushers will be collecting tickets at the door <strong>of</strong> each<br />
session. Tickets are available at the registration desk.<br />
Please note that space is limited.<br />
MI420 - Let’s Talk About Site-Specific Integration<br />
Room: L100 A<br />
Michele P. Calos, PhD<br />
MI421 - Transduction <strong>of</strong> Sick Hemotopoietic Stem <strong>Cell</strong>s<br />
Room: L100 B<br />
Odile Cohen-Haguenauer, MD, PhD<br />
MI422 - Liver Directed <strong>Gene</strong> <strong>Therapy</strong> for Hemophilia<br />
and Lysosomal Storage Disease<br />
Room: L100 C<br />
Katherine Ponder, MD<br />
MI423 - RNAi Based Therapies/Prospects and Problems<br />
Room: L100 D<br />
John J. Rossi, PhD<br />
MI424 - Assaying and Understanding Vector Insertion<br />
and Stem <strong>Cell</strong> Clonality<br />
Room: L100 E<br />
Christ<strong>of</strong> von Kalle, MD<br />
Presidential Symposium<br />
1:30 pm – 4:15 pm<br />
Room: Auditorium<br />
Chair<br />
Donald B. Kohn, MD<br />
Speakers<br />
Gordon Keller, PhD -<br />
Deriving Tissues from<br />
Embryonic Stem<br />
<strong>Cell</strong>s<br />
Catherine Verfaillie,<br />
MD - Unexpected<br />
Potency <strong>of</strong> Adult<br />
Stem <strong>Cell</strong>s: Fact or<br />
Fiction?<br />
Presentation <strong>of</strong> Top Three Abstracts<br />
#717 – Beverly L. Davidson, PhD – RNAi <strong>Therapy</strong> for<br />
Dominant Neurodegenerative Diseases<br />
#718 – Paul Gregorevic, PhD – Systemic <strong>Gene</strong> Transfer<br />
to Striated Muscles Using rAAV6 Vectors<br />
#719 – Hildegund Ertl, MD – E1-Deleted Adenoviral<br />
Vectors Persist in Activated Lymphocytes and Cause<br />
Continued Transgene Expression and Stimulation <strong>of</strong><br />
CD8+ Effector T <strong>Cell</strong>s<br />
45
Change language